Clinical Trial Update: Pharmacokinetic Interaction Between AZD3480 and Donepezil [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the pharmacokinetic interaction between AZD3480 and donepezil in Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AZD3480
• Aricept (Donepezil)

Snippet

Sponsor: AstraZeneca | Conditions: Alzheimer's Disease | Phase 1 | Status: TERMINATED